|
Study mode | Characterization | Key markers | Mechanism | Function (partly) | References |
|
Proliferation potential |
Human SCAPs | | | | | |
(i) STRO-1+/CD146+ (ii) STRO-1-/CD146+ | (i) Plastic adherent (ii) Osteo/odontogenic, adipogenic, neurogenic differentiation | STRO-1 | (i) (+) DSPP, BSP, ALP, BGLAP, BMP2, Runx2, NFL-L, nestin, NCAM, and β-tub-III | In vitro (i) As a marker for subpopulation (ii) With higher CFU efficiency | [81] |
Human PDLSCs | | | | | |
(i) ALP+ (ii) ALP- | (i) Plastic adherent (ii) Osteogenic, adipogenic, and neurogenic differentiation (iii) Positive for STRO-1, CD73, CD90, CD106, and CD146 | ALP | (i) (+) STRO-1, CD146 NANOG, OCT4, SOX | In vitro (i) As a marker for subpopulation (ii) Express higher level of stemness genes | [89] |
DFCs (rat) | | | | | |
(i) Overexpress NFIC | (i) Plastic adherent (ii) Colony formation (iii) Osteogenic and adipogenic differentiation (iv) Positive for CD29, CD44, CD90, and negative for CD34 and CD45 | NFIC | (i) (+) ALP, Col I, Runx2 | In vitro (i) As a marker for regulating DFCs (ii) Promote the proliferation and osteogenic/cementogenic differentiation | [91] |
Differentiation potential |
Human DPSCs | | CD146 | | | |
(i) CD146+ (ii) CD146- (iii) CD146+/- | (i) Plastic adherent (ii) Osteogenic and adipogenic differentiation | | (i) (+) ALP, osteocalcin, DMP1, DSPP | In vitro (i) As a marker for subpopulation (ii) With higher osteo/dentinogenic and adipogenic differentiation In vivo (i) Generated clear dentin/pulp-like structures | [98] |
Human DPSCs | | CD271/ p75 NTR, | | | |
(i) CD271+ (ii) CD271- | (i) Plastic adherent | | (i) (+) nestin, SOX1, SOX2 and SOX9 | In vitro (i) As a marker for subpopulation (ii) With greater neural differentiation potential | [102] |
Human DPSCs (i) STRO-1+/c-Kit+/CD34+ (ii) STRO-1+/c-Kit+/CD34- | (i) Plastic adherent (ii) Osteogenic and adipogenic differentiation | CD34 | (i) (+) CD271 and nestin, β-galactosidase, MAP-2, Neu-N, synapsin | In vitro (i) As a marker for subpopulation (ii) With higher efficiency of neurogenic commitment | [106] |
Human SCAPs | | WIF1 | | | |
(i) Overexpress WIF1 | (i) Plastic adherent | | (i) By activating OSX (ii) (+) ALP, DSPP, and DMP1 | In vitro (i) As a marker for regulating SCAPs (ii) Enhance dentinogenic differentiation potential In vivo (i) Generated greater bone/dentin-like tissues | [108] |
Human SCAPs | | GNAI3 | | | |
(i) Knockdown GNAI3 | (i) Plastic adherent (ii) Odonto/osteogenic differentiation (iii) Positive for CD44 and CD90 but negative for CD14 and CD45 | | (i) By suppressing JNK/ERK signaling (ii) (+) DSPP, Runx2, OSX, OPN, OCN, and BMP4 | In vitro (i) As a marker for regulating SCAPs (ii) Promoting proliferation, migration and odonto/osteogenic differentiation | [117] |
Immunomodulatory |
Human PDLSCs | | | | | |
(i) STRO-1+/CD146+ (97.1%) | (i) Plastic adherent | STRO-1/CD146 | (i) (-) CD1b | In vitro (i) As a combination of markers for subpopulation (ii) Regulating DC-mediated T-cell proliferation | [124] |
Cellular aging |
Human DPSCs | | | | | |
(i) Young DPSCs/MDPSCs (ii) Aged DPSCs/MDPSCs | (i) Plastic adherent (ii) Angiogenic, neurogenic, odontogenic/osteogenic, and adipogenic differentiation (iii) Positive for CD29, CD44, CD73, and CD90, and negative for CD31 | Migratory response to G-CSF | (i) A small age-dependent increase: SA-β-gal, p16, p21, IL-1β, IL-6, IL-8, Groα | In vitro (i) As a marker for subpopulation (ii) With high proliferation, migration, and regeneration potential is independent of age | [130] |
Human PDLSCs | | | | | |
(i) Activate YAP | (i) Plastic adherent (ii) Osteogenic, chondrogenic, and adipogenic differentiation (iii) Positive for CD44, CD73, CD90, and CD105), and negative for CD11b, CD19, CD34, CD45, HLA-DR | YAP | (i) (+) P-MEK, P-ERK, P-P90RSK and P-Msk (ii) (-) Bcl-2 family members (Bak, Bid, and Bik) | In vitro (i) As a marker for regulating PDLSCs (ii) Promote proliferation, accelerating the cell cycle, inhibiting apoptosis, and delaying senescence | [135, 136] |
Human DPSCs | | | | | |
(i) Overexpress TGF-β1 | (i) Plastic adherent (ii) Osteogenic, chondrogenic and adipogenic differentiation (iii) Positive for CD90, CD44, CD105, and CD73, and negative for CD34, CD45, CD11b, and HLA-DR | TGF-β1 | | In vitro (i) As a marker for regulating DPSCs (ii) Have positive effect on proliferation, cell cycle, and prevents cellular senescence and apoptosis | [40] |
|